Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “phaseI/II”

10 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 10 results

Testing effectiveness (Phase 2)Study completedNCT01558167
What this trial is testing

A Safety and Efficacy Trial of a Combination of Bendamustine, Rituximab and Lenalidomide in Patients With Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
German CLL Study Group 22
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07432022
What this trial is testing

A Phase I/II Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of the EMB-07 Combination Therapy in Patients With Aggressive B-Cell Non-Hodgkin Lymphoma

Who this might be right for
Combination TherapyAggressive B-Cell Non-Hodgkin LymphomaEMB07+1 more
Shanghai EpimAb Biotherapeutics Co., Ltd. 115
Testing effectiveness (Phase 2)Study completedNCT00209625
What this trial is testing

Phase I / II Study of Irinotecan (CPT-11) Combined With l-Leucovorin (l-LV) and 5-FU in Patients With Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Hokkaido Gastrointestinal Cancer Study Group 23
Testing effectiveness (Phase 2)Study completedNCT00987753
What this trial is testing

Study Evaluating the Safety and Tolerability of L-377202

Who this might be right for
Hormone Refractory Prostate CancerProstate Cancer
University of Alabama at Birmingham 13
Testing effectiveness (Phase 2)Active Not RecruitingNCT06052813
What this trial is testing

BN104 in the Treatment of Acute Leukemia

Who this might be right for
ALL, AdultAML, AdultAcute Leukaemia+4 more
Institut de Recherches Internationales Servier (I.R.I.S.) 66
Testing effectiveness (Phase 2)Study completedNCT00415506
What this trial is testing

Rituximab in the Treatment of Scleritis and Non-Infectious Orbital Inflammation

Who this might be right for
ScleritisOrbital Disease
Oregon Health and Science University 20
Testing effectiveness (Phase 2)Study completedNCT04621136
What this trial is testing

PhaseI/II Investigator-Initiated Trial to Investigate Safety and Efficacy of Ripasudil in Patients With Retinopathy of Prematurity

Who this might be right for
Retinopathy of Prematurity
Kyushu University 24
Early research (Phase 1)Study completedNCT00910728
What this trial is testing

Study to Assess the Safety of AZD1480 in Patients With Myeloproliferative Diseases

Who this might be right for
Primary Myelofibrosis (PMF)Post-Polycythaemia VeraEssential Thrombocythaemia Myelofibrosis
AstraZeneca 65
Testing effectiveness (Phase 2)Study completedNCT01076231
What this trial is testing

Proton Beam Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Can Be Removed By Surgery

Who this might be right for
Stage IIIA Non-small Cell Lung Cancer
Abramson Cancer Center at Penn Medicine 34
Testing effectiveness (Phase 2)Study completedNCT00818597
What this trial is testing

Extracorporeal Immune Support System (EISS) for the Treatment of Septic Patients

Who this might be right for
Severe Sepsis and Septic Shock
University of Rostock 10